Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reported on Sunday.[#item_full_content]
Hormuz, Tajani: “Non chiediamo una nuova operazione nel Golfo, impegno solo dopo la pace”
Read More [#item_full_content]